119 related articles for article (PubMed ID: 14870913)
1. Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.
Gharavi AE; Vega-Ostertag M; Espinola RG; Liu X; Cole L; Cox NT; Romagnoli P; Labat K; Pierangeli SS
Lupus; 2004; 13(1):17-23. PubMed ID: 14870913
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.
Gharavi AE; Pierangeli SS; Espinola RG; Liu X; Colden-Stanfield M; Harris EN
Arthritis Rheum; 2002 Feb; 46(2):545-52. PubMed ID: 11840458
[TBL] [Abstract][Full Text] [Related]
3. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
4. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
5. New developments in viral peptides and APL induction.
Gharavi AE; Pierangeli SS; Harris EN
J Autoimmun; 2000 Sep; 15(2):227-30. PubMed ID: 10968915
[TBL] [Abstract][Full Text] [Related]
6. Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies.
Gharavi AE; Pierangeli SS; Harris EN
Immunobiology; 2003; 207(1):37-42. PubMed ID: 12638901
[TBL] [Abstract][Full Text] [Related]
7. Origin of antiphospholipid antibodies: induction of aPL by viral peptides.
Gharavi AE; Pierangeli SS
Lupus; 1998; 7 Suppl 2():S52-4. PubMed ID: 9814674
[TBL] [Abstract][Full Text] [Related]
8. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
[TBL] [Abstract][Full Text] [Related]
9. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.
de la Torre YM; Pregnolato F; D'Amelio F; Grossi C; Di Simone N; Pasqualini F; Nebuloni M; Chen P; Pierangeli S; Bassani N; Ambrogi F; Borghi MO; Vecchi A; Locati M; Meroni PL
J Autoimmun; 2012 May; 38(2-3):J209-15. PubMed ID: 22196923
[TBL] [Abstract][Full Text] [Related]
10. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
11. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
[TBL] [Abstract][Full Text] [Related]
13. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides.
Gharavi EE; Chaimovich H; Cucurull E; Celli CM; Tang H; Wilson WA; Gharavi AE
Lupus; 1999; 8(6):449-55. PubMed ID: 10483013
[TBL] [Abstract][Full Text] [Related]
14. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
16. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
Levine JS; Subang R; Koh JS; Rauch J
J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
18. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI.
García CO; Kanbour-Shakir A; Tang H; Molina JF; Espinoza LR; Gharavi AE
Am J Reprod Immunol; 1997 Jan; 37(1):118-24. PubMed ID: 9138445
[TBL] [Abstract][Full Text] [Related]
19. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of antiphospholipid syndrome.
Gharavi AE; Wilson W; Pierangeli S
Lupus; 2003; 12(8):579-83. PubMed ID: 12945715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
